Our Analysis
The New York Times traced the journey of one of the most basic medical supplies — saline solution, which is essentially sterile saltwater — from manufacturer to patient bill. The manufacturing cost: 44 cents to $1 per bag. The hospital charge: $91 to $546 per bag.
Saline is a commodity product. It's water and salt, sterilized and sealed. There is no patent, no complex manufacturing process, no expensive ingredient. Yet through a chain of middlemen, group purchasing organizations, and hospital markups, the price inflates by 500x or more by the time it appears on a patient's bill.
The article exposed how healthcare supply chains operate as a series of opaque markups, each layer adding cost without adding value. Group purchasing organizations negotiate prices that aren't actually low. Distributors add margins. Hospitals apply their chargemaster multiplier. And the patient — the only person actually paying — never sees any of these intermediate prices.
This investigation crystallized a fundamental truth about healthcare pricing: the problem isn't that healthcare is inherently expensive. It's that the pricing system is designed to obscure costs and prevent the normal market forces that would keep them rational.
Original source
Read the original article on New York TimesKey Takeaways
Saline solution costs under $1 to manufacture but is billed at $91-$546 per bag
Healthcare supply chains add hundreds of percent in markup through opaque intermediaries
Group purchasing organizations, which claim to reduce costs, often do the opposite
The pricing system is designed to obscure costs, not reduce them
Why It Matters for PricePain
If a bag of saltwater can be marked up 500x, imagine what's happening with every other item on your hospital bill. This is exactly why price transparency matters — not just for big-ticket procedures, but for every line item. PricePain makes these prices visible so patients can make informed choices and providers must compete on value.